Edwards Lifesciences Corporation
Price Action
Technical Summary
EMERGING TRENDEdwards Lifesciences Corporation is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 50), indicating performance broadly in line with the market. Earnings contraction of 75% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $81.10 | +2.59% | ABOVE |
| 50 SMA | $82.23 | +1.18% | ABOVE |
| 100 SMA | $82.53 | +0.81% | ABOVE |
| 150 SMA | $82.06 | +1.39% | ABOVE |
| 200 SMA | $81.16 | +2.52% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is EW in an uptrend right now?
EW has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is EW overbought or oversold?
EW's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.
Is EW outperforming the market?
EW has a Relative Strength (RS) Rating of 50 out of 99. EW is performing about average compared to the market.
Where is EW in its 52-week range?
EW is trading at $83.20, which is 95% of its 52-week high ($87.89) and 70% above its 52-week low ($72.30).
How volatile is EW?
EW has a Beta of 0.65 and 52-week volatility of 23%. It's less volatile than the S&P 500 - generally more stable.